Miami, FLNCT07580716Now EnrollingIRB Ready

Primary Knee Osteoarthritis Clinical Trial in Miami, FL

Access cutting-edge primary knee osteoarthritis treatment through this phase 2 clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.

Sponsored by Enlivex Therapeutics Ltd.

Quick Self-Assessment

See if you qualify for this Miami location

Preparing your pre-screening questions…

Expert Care in Miami

Access primary knee osteoarthritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary knee osteoarthritis treatment provided free

Apply for This Miami Location

Check if you qualify for this primary knee osteoarthritis clinical trial in Miami, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Miami

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Miami site if eligible
  4. 4Begin participation

About This Primary Knee Osteoarthritis Study in Miami

This is a multicenter, randomized, double-blind, placebo-controlled, Phase IIb study to evaluate intra-articular (IA) injections of Allocetra in participants with moderate-to-severe age related symptomatic primary knee osteoarthritis (OA).

Sponsor: Enlivex Therapeutics Ltd.

Who Can Participate

Inclusion Criteria

Participants must meet all of the inclusion criteria listed below to be eligible for the study:
Age 64 years or above.
Diagnosis of primary femorotibial knee OA.
Radiographic evidence of knee OA defined as Kellgren-Lawrence (KL) grade 2 or 3 in the index knee.
Participants who are intolerant to, or have failed to adequately respond to at least 2 OA therapies.
Index knee pain assessed during the screening period and following wash-out of pain medications.
Willingness to abstain from prohibited medications/treatments during the trial.
Women who are postmenopausal (≥12 months natural amenorrhea without alternative cause) or surgically sterilized (bilateral tubal ligation, bilateral oophorectomy, or hysterectomy).
Male participants with partners of childbearing potential, who are not surgically sterile (vasectomy) for at least 6 months prior to randomization, must use condoms with spermicide in addition to their partner's contraception from randomization and for 90 days after last dose.

Exclusion Criteria

Participants will be excluded from the study if they meet any of the following criteria:
Severe or end-stage osteoarthritis of the index knee.
Clinically significant structural abnormalities or instability of the index knee.
Recent major injury, surgical procedure, or intra-articular treatment in the index knee.
Any known history of infection or tumor of the index knee, or active infection at the intended injection site.
Any known history of inflammatory arthropathy or crystal-deposition disease.
Any severe systemic cartilage, bone, or musculoskeletal disorder that may interfere with study outcomes.
Clinically significant widespread pain syndromes.
Immunosuppressive therapy, clinically significant immunodeficiency, or active infection.
Body Mass Index (BMI) \>40 kg/m²
Use of medications that may interfere with pain assessment or study outcomes.
Known coagulopathy or use of anticoagulant/antiaggregant medication.
Significant uncontrolled systemic disease or clinically significant findings on screening laboratory tests or physical examination.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Miami?

Yes, this clinical trial (NCT07580716) has an active research site in Miami, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Knee Osteoarthritis Treatment Options in Miami, FL

If you're searching for primary knee osteoarthritis treatment options in Miami, FL, this clinical trial (NCT07580716) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Miami research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced primary knee osteoarthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary knee osteoarthritis clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in Miami, FL

See all osteoarthritis clinical trials recruiting in Miami — not just this study.

Browse Osteoarthritis Trials in Miami →

Browse More Trials by Condition

Osteoarthritis TrialsAll Conditions →

Ready to Join in Miami?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Miami, FL